Berberine in oral diseases: molecular mechanisms and therapeutic implications
Frontiers in Pharmacology · 02.07.2026 · 17
DOI: 10.3389/fphar.2026.1853738 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 02.07.2026. Verfasst von Siyuan Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Henan University, Kaifeng, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Oral diseases, including periodontitis, oral mucosal diseases, dental caries, endodontic diseases, and oral cancer, are among the most prevalent diseases worldwide and impose substantial health and economic burdens. Current therapeutic strategies are often limited by incomplete efficacy, drug resistance, or adverse effects, highlighting the need for alternative pharmacological approaches. Berberine, a natural isoquinoline alkaloid derived from medicinal plants such as Coptis chinensis and Phellodendron species, has attracted increasing attention because of its broad pharmacological properties. Accumulating evidence indicates that berberine exerts antimicrobial, anti-inflammatory, antioxidant, bone-regulating, and antitumor effects, which are closely associated with key pathogenic mechanisms involved in oral diseases. This review systematically summarizes the pleiotropic pharmacological effects of berberine and discusses its mechanistic roles in the management of periodontitis, recurrent aphthous ulcers, oral candidiasis, dental caries, pulpitis and apical periodontitis, and oral cancer. In addition, recent advances aimed at improving the bioavailability of berberine through novel drug delivery systems, including nanocarriers and hydrogels, are summarized. Finally, current challenges and future research directions are proposed to facilitate the clinical translation of berberine-based therapies in oral diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Stomatology, Henan University, Kaifeng, China.
- Kaifeng Key Laboratory of Periodontal Tissue Engineering, Kaifeng, China.
- Department of Stomatology, Henan Provincial People's Hospital, Zhengzhou, China.
Zitieren
APA
Wu, S., Wang, B., Zhu, J., Chen, H., & Zhai, Y. (2026). Berberine in oral diseases: molecular mechanisms and therapeutic implications. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1853738
Vancouver
Wu S, Wang B, Zhu J, Chen H, Zhai Y. Berberine in oral diseases: molecular mechanisms and therapeutic implications. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1853738
BibTeX
@article{Wu2026,
author = {Wu, Siyuan and Wang, Bowen and Zhu, Jiaqi and Chen, Hongli and Zhai, Yuankun},
title = {Berberine in oral diseases: molecular mechanisms and therapeutic implications},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1853738}
}
EUVIMED